| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |